Development of oral candidiasis following initiation and rechallenge of extended-release bupropion in a geriatric patient

The Mental Health Clinician
Nina VadieiErica C Garcia-Pittman

Abstract

To report a case of oral candidiasis that developed in a 70-year-old white female both upon initiation and rechallenge of extended-release bupropion therapy. A 70-year-old female with a past medical history of osteoarthritis, degenerative joint disease, and polycythemia vera developed oral candidiasis on 2 occasions following initiation of extended-release bupropion for the treatment of recurrent depression. During both instances, the reaction occurred with an increased dose of the medication, suggesting the adverse event may have been dose-related. The patient had no risk factors for oral candidiasis aside from dry mouth at baseline that reportedly worsened on bupropion. Though there are no other reports to our knowledge describing the development of oral candidiasis with bupropion, the likelihood of this having been an adverse reaction in this patient is probable as indicated by a calculated score of 8 from the Naranjo Algorithm. The adverse event appeared following bupropion administration and improved over time following its discontinuation. The adverse event reappeared following readministration of the agent, and no alternative causes were able to be identified. Additionally, the reaction occurred following an increase in ...Continue Reading

References

Feb 1, 1987·Journal of Dental Research·M M Schubert, K T Izutsu
Sep 1, 1984·Journal of Dental Research·H Ben-AryehD Gutman
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Sep 1, 1995·Journal of Clinical Pharmacology·R A SweetC L DeVane
May 19, 2000·The Journal of Clinical Psychiatry·K L WeihsJ A Ascher
Apr 3, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J D VanderkooyR Michael Bagby
Jan 31, 2003·The Journal of the American Dental Association·James Guggenheimer, Paul A Moore
Mar 12, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Molly R. FortnerP Murali Doraiswamy
Sep 14, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Stephen M. StahlSusan Learned-Coughlin
Jul 20, 2005·Primary Care Companion to the Journal of Clinical Psychiatry·Maurizio FavaJ Andrew Johnston
Sep 21, 2005·Archives of Dermatology·Richard E Kast, Eric L Altschuler
Jul 19, 2011·General Hospital Psychiatry·Chien-Kuan ChiangChih-Sung Liang
Nov 28, 2013·Postȩpy dermatologii i alergologii·Zuzanna SlebiodaAnna Kowalska
Nov 5, 2014·Journal of Oral and Maxillofacial Pathology : JOMFP·Arun SinghAshutosh Agrawal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Related Papers

Nouvelle Revue Française D'hématologie
J Bernard
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
Rebecca L DunnMark A Stratton
Schweizerische medizinische Wochenschrift
H W PABSTT KELLERMANN
© 2022 Meta ULC. All rights reserved